clinical trials

News

GSK drug raises hopes for patients with PBC itch

GSK has reported promising results with a drug to treat the severe itching that plagues patients with rare cholestatic liver disease primary biliary cholangitis (PBC).

News

J&J plots filings after psoriasis drug clears phase 3 test

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial.

News

Neurogene falls again on Rett gene therapy side effects

Neurogene has halted patient enrolment in the high-dose arm of its trial of Rett syndrome gene therapy, sparking another run on its shares.

News

female scientist conducting experiment in a laboratory

Tirzepatide gets a big win in obesity-related heart failure

Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the

Patients

Tips to strengthen clinical trials by improving the patient ...

From consumer products to clinical trials, anything that is designed without input from its intended recipients will likely feel disconnected from their needs.

News

Bone marrow aspirate showing the histologic correlate of multiple myeloma under the microscope, H&E stain

GSK hails survival data with revived myeloma drug Blenrep

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached stat

GSK drug raises hopes for patients with PBC itch

J&J plots filings after psoriasis drug clears phase 3 test

Neurogene falls again on Rett gene therapy side effects

Tirzepatide gets a big win in obesity-related heart failure

Tips to strengthen clinical trials by improving the patient ...

GSK hails survival data with revived myeloma drug Blenrep

EU clears first drug therapy for rare disease cALD

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks